Murphy & Mullick Capital Management Corp »

Verve Therapeutics shares owned by Murphy & Mullick Capital Management Corp

Quarter-by-quarter ownership of Verve Therapeutics shares owned by Murphy & Mullick Capital Management Corp from 13F filings

Historical chart of Murphy & Mullick Capital Management Corp investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Murphy & Mullick Capital Management Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Murphy & Mullick Capital Management Corp

Quarter filed Position value Share count Share price at filing
2025-09-30 $0 43 0.00
2025-06-30 $0 43 0.00

More positions owned by Murphy & Mullick Capital Management Corp

NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Broadcom (AVGO)
Schwab Us Large Cap Gr Etf Etf (SCHG)
Microsoft Corporation (MSFT)
Charles Schwab Us Mc Etf (SCHM)
Schwab Us Large Cap Va Etf Etf (SCHV)
Palantir Technologies (PLTR)
Alphabet Inc Class A cs (GOOGL)
Schwab Us Small Cap Etf Etf (SCHA)
Spdr S&p 500 Etf Etf (SPY)
Schwab International Etf (SCHF)
Apple (AAPL)
Amazon (AMZN)
Vanguard Intermediate Uie (VCIT)

View all positions for Murphy & Mullick Capital Management Corp

Top funds holding Verve Therapeutics

Cim Investment Mangement
GAMMA Investing
Murphy & Mullick Capital Management Corp

View all funds holding Verve Therapeutics